Call Today:
 

Tel: +1 (844) 792-6300

Address:
 
Thrombolex, Inc.
75 Britain Drive

New Britain, PA 18901​

  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

© 2019 by Thrombolex™   |   All Rights Reserved    |    Disclaimers    

Home / Products

 Watch to learn about BASHIR™ Endovascular Catheter's exclusive features.
The Innovator

Riyaz Bashir, MD, FACC, RVT, Professor of Medicine for the Lewis Katz School of Medicine at Temple University, (Philadelphia, PA) and Director of Vascular and Endovascular Medicine at Temple University Hospital, created Bashir Endovascular Catheters to dissolve  large blood clots quickly and effectively, to improve the quality of life for patients suffering from venous thromboembolic (VTE) conditions.

In his words, “VTE has become a significant health concern in the U.S…causing up to 100,000 deaths each year.  My inspiration was to develop a device that would provide better treatment outcomes by enhancing both endogenous and exogenous fibrinolysis.”

Our Solution

BASHIR™ endovascular catheters are the first interventional catheters to rapidly create multiple channels so the patient’s own endogenous lytics can flow into the culprit thrombus.

The Problem

VTE is an under-recognized and under-treated condition: it’s the third leading cause of cardiovascular related death.

How the BASHIR™ endovascular catheter works
  • Immediately forms a large central channel for blood flow through a clot when the mini-infusion catheters are expanded.

 

  • Creates a series of cross-sectional channels through the occlusive thrombus, permitting the patient’s own blood flow and its endogenous lytics to dissolve the clot.

 

  • Permits infusion of fluids including exogenous lytics to saturate the clot through its 6 mini-infusion catheters with 48 precision-drilled holes intended to synergistically enhance the efficiency of the therapy.

How We're Different

The Proof of Principle Study in a model of thrombosis in the vena cava, using the BASHIR™ endovascular catheter with the administration of r-tPA, resulted in 80% lysis of a 30cc clot burden in only 4 hours.

Our Purpose

​BASHIR™ Endovascular Catheters should play a key role in improving the quality of life for patients suffering from VTE conditions.

Available Now:

The BASHIR™ Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature.

The BASHIR™ N-X Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, into the peripheral vasculature, including the pulmonary arteries.

Need more details? Contact us.

We are here to assist. Contact us by phone, email or via our social media channels.